Skip to main content
Watch Insiders
NONE filings

Corporate insider profile

Edward A Mule Filing Activity

Latest reported as 10% Owner of Keenova Therapeutics plc (NONE).

Purchase filings
2
Reported companies
1
Net open-market value
$97,416,264
Latest transaction
May 20, 2026

Affiliated corporations

Reported company relationships

NONELatest reported

Keenova Therapeutics plc

10% Owner

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
May 20, 2026Keenova Therapeutics plc (NONE)10% OwnerOpen Market Purchase397,500$90.50$35,973,750
Apr 17, 2026Keenova Therapeutics plc (NONE)10% OwnerOpen Market Purchase685,000$89.70$61,442,514